Chalcogen Bonded Directly To A Ring Carbon Of The 1,3-diazine Ring Patents (Class 514/259.5)
  • Treatment of dementia and neurodegenerative diseases with intermediate doses of LHRH antagonists
    Publication number: 20020177556
    Abstract: The present invention relates to the treatment of dementia and neurodegenerative diseases like Alzheimer's disease with intermediate doses of LHRH antagonists which do not cause a castration. A preferred LHRH antagonist is cetrorelix.
    Type: Application
    Filed: April 27, 2002
    Publication date: November 28, 2002
    Inventors: Jurgen Engel, Rainer Voegeli
  • Nitrogen-containing heterocyclic compounds, their production and use
    Publication number: 20020103210
    Abstract: A compound of the formula: 1
    Type: Application
    Filed: January 11, 2002
    Publication date: August 1, 2002
    Applicant: TAKEDA CHEMICAL INDUSTRIES, LTD.
    Inventors: Shuichi Furuya, Toshihiro Imaeda, Satoshi Sasaki
  • Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
    Publication number: 20020077327
    Abstract: GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women.
    Type: Application
    Filed: September 28, 2001
    Publication date: June 20, 2002
    Applicant: Neurocrine Biosciences, Inc.
    Inventors: Yun-Fei Zhu, Keith M. Wilcoxen, R. Scott Struthers, Chen Chen, Patrick J. Connors, Yinghong Gao, Fabio C. Tucci